Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Sherbrooke

$38,000.00

Molecular basis of bacterial small-colony variants / Base moléculaire des variants à petites colonies chez les bactéries

EF 2016-17

Résumé
Staphylococcus aureus (SA) and antibiotic resistant methicillin-resistant SA (MRSA) often cause chronic and difficult-to-treat infections. SA/MRSA are able to generate Small-Colony Variants (SCVs), which have been linked to persistent infections. The ability of SA/MRSA to switch to SCVs and vice versa seems to be an integral part the infection process leading to persistence. Compared to their normal counterparts, bacterial SCVs produce high amounts of protective biofilms (extracellular matrix in which bacteria are embedded). SCVs also have a great ability to survive and persist within host cells, a property that protects them from the host immune response. The switch to SCVs also facilitates the development of antibiotic resistance making SA/MRSA infections even more difficult to treat. This research program aims to study the molecular basis of SCV formation. The specific objectives are to: 1) Investigate the molecular basis of SCV formation through whole-genome sequencing (DNA and RNA) of genetically-related ""SA-SCV"" pairs; 2) Investigate the molecular basis of antibiotic resistance development occurring through SCVs; 3) Study the impact of SCV formation on virulence and persistence in the mammalian host; and 4) Establish the molecular basis of future strategies targeting SCVs. In Objectives 1 and 2, genome and transcriptome alterations responsible for the SCV phenotype will be identified. We expect finding different paths leading to SCV formation since several phenotypic expressions exist. We will then use a variety of in vitro, cellular and animal models to investigate how the different molecular mechanisms of SCV formation impact on virulence and persistence in the host (Objective 3). Objective 4 will built on these results to investigate and establish the molecular basis of new approaches to control SCVs such as the development of vaccines specifically tailored to target intracellular SA. Chronic lung infection is the most common cause of morbidity and mortality in cystic fibrosis (CF) patients. SA/MRSA is overall the most frequently isolated pathogen from CF patients and SCVs contribute to the persistence of infection. Studies have demonstrated the deleterious effects of SCVs and of MRSA on CF in children and adults, respectively. SCVs are also involved in the persistence of other diseases like bovine mastitis. Milk production is an important industry in Canada. Total losses linked to mastitis in dairy herds are estimated at over $400 million per year and SA is the leading cause of bovine mastitis in Canada. No SA vaccine has shown protective efficacy to date, in part because of the inadequacy of the immune response to counteract intracellular forms of SA. With the understanding of the fundamental mechanisms explaining the formation of SCVs, this research program will help the future development of specific antibiotics or vaccines that prevent SCV formation and SA/MRSA persistence.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2015-05916
Name nom
Malouin, Francois
Department département
Biologie - Biologie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2015
Award amount
38000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
2
Nb partie
5
Application title
Molecular basis of bacterial small-colony variants / Base moléculaire des variants à petites colonies chez les bactéries
Keyword
NSERC
Application summary
Staphylococcus aureus (SA) and antibiotic resistant methicillin-resistant SA (MRSA) often cause chronic and difficult-to-treat infections. SA/MRSA are able to generate Small-Colony Variants (SCVs), which have been linked to persistent infections. The ability of SA/MRSA to switch to SCVs and vice versa seems to be an integral part the infection process leading to persistence. Compared to their normal counterparts, bacterial SCVs produce high amounts of protective biofilms (extracellular matrix in which bacteria are embedded). SCVs also have a great ability to survive and persist within host cells, a property that protects them from the host immune response. The switch to SCVs also facilitates the development of antibiotic resistance making SA/MRSA infections even more difficult to treat. This research program aims to study the molecular basis of SCV formation. The specific objectives are to: 1) Investigate the molecular basis of SCV formation through whole-genome sequencing (DNA and RNA) of genetically-related ""SA-SCV"" pairs; 2) Investigate the molecular basis of antibiotic resistance development occurring through SCVs; 3) Study the impact of SCV formation on virulence and persistence in the mammalian host; and 4) Establish the molecular basis of future strategies targeting SCVs. In Objectives 1 and 2, genome and transcriptome alterations responsible for the SCV phenotype will be identified. We expect finding different paths leading to SCV formation since several phenotypic expressions exist. We will then use a variety of in vitro, cellular and animal models to investigate how the different molecular mechanisms of SCV formation impact on virulence and persistence in the host (Objective 3). Objective 4 will built on these results to investigate and establish the molecular basis of new approaches to control SCVs such as the development of vaccines specifically tailored to target intracellular SA. Chronic lung infection is the most common cause of morbidity and mortality in cystic fibrosis (CF) patients. SA/MRSA is overall the most frequently isolated pathogen from CF patients and SCVs contribute to the persistence of infection. Studies have demonstrated the deleterious effects of SCVs and of MRSA on CF in children and adults, respectively. SCVs are also involved in the persistence of other diseases like bovine mastitis. Milk production is an important industry in Canada. Total losses linked to mastitis in dairy herds are estimated at over $400 million per year and SA is the leading cause of bovine mastitis in Canada. No SA vaccine has shown protective efficacy to date, in part because of the inadequacy of the immune response to counteract intracellular forms of SA. With the understanding of the fundamental mechanisms explaining the formation of SCVs, this research program will help the future development of specific antibiotics or vaccines that prevent SCV formation and SA/MRSA persistence.